Cargando…

Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease

Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a complementary marker for traditional clinical markers to improve diagnostic accuracy and also help in developing new pharmacotherapeutic trials. It has been revealed that longitudinal analysis of the whole bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Farzan, Ali, Mashohor, Syamsiah, Ramli, Rahman, Mahmud, Rozi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305898/
https://www.ncbi.nlm.nih.gov/pubmed/22035255
http://dx.doi.org/10.1186/1746-1596-6-105

Ejemplares similares